Mirae Asset Global Investments’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
Other funds holding VYGR
AC
VPC
OM
Mirae Asset Global Investments's VYGR Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Voyager Therapeutics (VYGR) stake by 12% in Q2 2026, selling an estimated $1.41K and leaving 2,702 shares worth $9.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1577.
Mirae Asset Global Investments first reported a position in VYGR in Q2 2020 and has held it in 17 quarters since. The position peaked at $571K in Q2 2021. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.
- Mirae Asset Global Investments held 2,702 shares of Voyager Therapeutics worth $9.46K as of Q2 2026.
- Mirae Asset Global Investments sold 372 Voyager Therapeutics shares in Q2 2026, an estimated $1.41K.
- Voyager Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1577 holding.
- Mirae Asset Global Investments first reported a position in Voyager Therapeutics in Q2 2020 and has held it in 17 quarters since.
- Mirae Asset Global Investments's Voyager Therapeutics position peaked at $571K in Q2 2021.
- 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.